531 related articles for article (PubMed ID: 19370512)
1. Perinatal outcomes in pregnancies managed with antenatal insulin glargine.
Egerman RS; Ramsey RD; Kao LW; Bringman JJ; Haerian H; Kao JL; Bush AJ
Am J Perinatol; 2009 Sep; 26(8):591-5. PubMed ID: 19370512
[TBL] [Abstract][Full Text] [Related]
2. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.
Fang YM; MacKeen D; Egan JF; Zelop CM
J Matern Fetal Neonatal Med; 2009 Mar; 22(3):249-53. PubMed ID: 19330710
[TBL] [Abstract][Full Text] [Related]
3. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
Durnwald CP; Landon MB
J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
[TBL] [Abstract][Full Text] [Related]
4. Use of insulin glargine during pregnancy: a case-control pilot study.
Price N; Bartlett C; Gillmer M
BJOG; 2007 Apr; 114(4):453-7. PubMed ID: 17261126
[TBL] [Abstract][Full Text] [Related]
5. Survey of glargine use in 115 pregnant women with Type 1 diabetes.
Gallen IW; Jaap A; Roland JM; Chirayath HH
Diabet Med; 2008 Feb; 25(2):165-9. PubMed ID: 18215174
[TBL] [Abstract][Full Text] [Related]
6. Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study.
Negrato CA; Rafacho A; Negrato G; Teixeira MF; Araújo CA; Vieira L; Silva CA; Date SK; Demarchi AC; Gomes MB
Diabetes Res Clin Pract; 2010 Jul; 89(1):46-51. PubMed ID: 20378197
[TBL] [Abstract][Full Text] [Related]
7. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy.
Lapolla A; Dalfrà MG; Masin M; Bruttomesso D; Piva I; Crepaldi C; Tortul C; Dalla Barba B; Fedele D
Acta Diabetol; 2003 Sep; 40(3):143-9. PubMed ID: 14605971
[TBL] [Abstract][Full Text] [Related]
8. A retrospective review of glargine use in pregnancy.
Henderson CE; Machupalli S; Marcano-Vasquez H; Kerr P; Reilly KD
J Reprod Med; 2009 Apr; 54(4):208-10. PubMed ID: 19438161
[TBL] [Abstract][Full Text] [Related]
9. Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis.
Pollex E; Moretti ME; Koren G; Feig DS
Ann Pharmacother; 2011 Jan; 45(1):9-16. PubMed ID: 21205954
[TBL] [Abstract][Full Text] [Related]
10. Maternal and perinatal outcomes in women with gestational diabetes mellitus as compared to nondiabetic controls.
Sendag F; Terek MC; Itil IM; Oztekin K; Bilgin O
J Reprod Med; 2001 Dec; 46(12):1057-62. PubMed ID: 11789086
[TBL] [Abstract][Full Text] [Related]
11. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR
Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069
[TBL] [Abstract][Full Text] [Related]
12. Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy.
Smith JG; Manuck TA; White J; Merrill DC
Am J Perinatol; 2009 Jan; 26(1):57-62. PubMed ID: 18979406
[TBL] [Abstract][Full Text] [Related]
13. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
[TBL] [Abstract][Full Text] [Related]
14. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
[TBL] [Abstract][Full Text] [Related]
15. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
[TBL] [Abstract][Full Text] [Related]
16. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
Päivärinta M; Tapanainen P; Veijola R
Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
[TBL] [Abstract][Full Text] [Related]
17. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.
Ramos GA; Jacobson GF; Kirby RS; Ching JY; Field DR
J Perinatol; 2007 May; 27(5):262-7. PubMed ID: 17363911
[TBL] [Abstract][Full Text] [Related]
18. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
20. Safety of insulin analogs during pregnancy: a meta-analysis.
Lv S; Wang J; Xu Y
Arch Gynecol Obstet; 2015 Oct; 292(4):749-56. PubMed ID: 25855052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
